ArticleNuclear medicine and molecular imaging2018

Evaluation of RECIST, PERCIST, EORTC, and MDA Criteria for Assessing Treatment Response with Ga68-PSMA PET-CT in Metastatic Prostate Cancer Patient with Biochemical Progression: a Comparative Study.

Manoj Gupta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.